TCL Archive Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial December 25, 2009
TCL Archive As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray December 13, 2002
TCL Archive Cooperative Groups Advised to Prepare for 10 Percent Budget Cut, Begin Slowing Patient Accrual. Groups Say Cuts Would Jeopardize Clinical Trials Program. October 27, 2006